Is r-biopharm.com Safe? Security Analysis for R-Biopharm AG
http://r-biopharm.comCheck if r-biopharm.com is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for r-biopharm.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
R-Biopharm AG is a well-established German company specializing in clinical diagnostics, food and feed analysis, and nutrition care solutions. With over 35 years of experience and a presence in more than 120 countries, the company offers a broad portfolio of innovative products and services targeting healthcare professionals and the food industry. Their website reflects a professional and content-rich digital presence, supporting multiple languages and providing comprehensive information about their divisions and corporate responsibility initiatives. Technically, the site is built on WordPress with modern SEO and marketing tools, though performance could be improved. Security posture is currently weak due to the absence of a valid SSL certificate and HTTPS support, which is a critical risk that should be addressed immediately. Privacy compliance is strong, with clear policies and cookie consent mechanisms in place. Overall, the company demonstrates high business credibility and trustworthiness, but must prioritize securing their web infrastructure to protect users and maintain reputation.
Detected Technologies
9 urgent findings need attention
3 critical · 6 high
- + 1 more findings in the full report below
Keep r-biopharm.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
4 findings
70/100
GDPR Compliance
6 findings
18/100
NIS2 Compliance
8 findings
5/100
Email Security
1 finding
50/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
The company operates primarily in the healthcare sector, focusing on diagnostics and food safety analytics. Their business model is B2B, serving laboratories, healthcare providers, and food/feed industries. The presence of multiple specialized subdomains and a dedicated e-commerce shop indicates diversified revenue streams and a mature digital ecosystem. The company leverages partnerships, such as Nutrition Care, to expand its market reach. Their corporate social responsibility and certified quality programs enhance brand trust. The website's multilingual support and extensive product portfolio suggest a global market orientation and strong competitive positioning.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Security Posture Analysis
Comprehensive Security Assessment
The website currently lacks a valid SSL certificate, resulting in no HTTPS support, which is a critical security vulnerability exposing users to potential data interception and undermining trust. While some security headers like X-Frame-Options and Content-Security-Policy are present, the CSP includes unsafe directives that weaken its effectiveness. No known SSL/TLS vulnerabilities are detected, but the absence of modern TLS protocols and OCSP stapling reduces security and performance. The site uses secure forms and cookie consent mechanisms, indicating awareness of privacy requirements. Incident response and vulnerability disclosure policies are not found, suggesting areas for improvement in security governance.
Strategic Recommendations
Priority Actions for Security Improvement
Immediately install and maintain a valid SSL/TLS certificate to enable HTTPS across the entire site.
Get this report delivered to your inbox
Receive a summary of the r-biopharm.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Insufficient contact information
MEDIUMGDPR requires organizations to provide clear contact details
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
No HTTPS encryption
CRITICALGDPR requires appropriate security measures for personal data
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No HTTPS encryption
CRITICALNIS2 requires appropriate technical measures including encryption
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete r-biopharm.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
Email Security Check Incomplete
MEDIUMSome email security checks timed out
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
No HTTPS Encryption
CRITICALWebsite does not use HTTPS encryption, making all data transmission vulnerable to interception
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
DNS Records
DNSSEC Status
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Service Exposed: SSH
MEDIUMPort 22 (SSH) is publicly accessible - SSH - Secure but can be brute-forced
How does r-biopharm.com compare?
r-biopharm.com scores below average. Browse similar domains to see how competitors handle security.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the r-biopharm.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Want OffSeq to fix this?
Book a 30-minute remediation call
Our security engineers can resolve the high-severity findings identified in this report — from SSL misconfigurations and missing headers to compliance gaps and infrastructure hardening.
OffSeq provides end-to-end cybersecurity services: penetration testing, vulnerability remediation, compliance consulting, and continuous monitoring. View all services
Scan your own website
Liked the r-biopharm.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about r-biopharm.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published